To Evaluate Oral Health and Quality of Life Associated With Use of a Denture Adhesive

Exclusion Criteria

• •1. A participant who is an employee of the investigational site, either directly involved in the conduct of the study or a member of their immediate family; or an employee of the investigational site otherwise supervised by the investigator; or, a GlaxoSmithKline Consumer Healthcare (GSKCH) employee directly involved in the conduct of the study or a member of their immediate family.
• •2. A participant who has participated in other studies (including non-medicinal studies) involving investigational product(s) within 30 days prior to study entry and/or during study participation.
• •3. A participant with, in the opinion of the investigator or medically qualified designee, an acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or investigational product administration or may interfere with the interpretation of study results and, in the judgment of the investigator or medically qualified designee, would make the participant inappropriate for entry into this study.
• •4. A participant who is a pregnant female.
• •5. A participant who is a breastfeeding female.
• •6. A participant with known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients.
• •7. A participant who, in the opinion of the investigator or medically qualified designee, should not participate in the study.
• •8. A participant unwilling or unable to comply with the Lifestyle Considerations:
• •1. Participants will not be permitted to have any dental/denture work performed during the time they are in the study, unless discussed and permitted by the examiner. This is to ensure that the denture fit will not be altered during the study.
• •2. Participants will not be able to use any denture adhesive product other than that supplied by the investigator.
• •3. Participants should continue using their usual denture cleansing methodology throughout the study.
• •9. A participant who has previously been enrolled in this study.
• •10. A participant who has had recent (within 30 days) gingival surgery.
• •11. Taking or have taken a bisphosphonate drug (i.e. Fosamax, Actonel, Boniva).
• •12. A participant with any clinically significant or relevant oral abnormality (e.g. temporomandibular joint problems) that, in the opinion of the investigator, could affect the Participant's participation in the study.
• •13. A participant with any condition or medication which, in the opinion of the investigator, is currently causing xerostomia.
• •14. A participant with recent history (within the last year) of alcohol or other substance abuse.
• •15. A participant with OST examination findings such as stomatitis, open sores, lesions, or swelling which in the opinion of the investigator, would interfere with the conduct of the study. Mild, chronic conditions commonly expected from the use of dentures in the investigators opinion, are acceptable in this study.
• •16. A participant who is using any medication that, in the opinion of the investigator, would interfere with the conduct of the study